Wuhan Kindstar Diagnostics: Kindstar Globalgene Proposed Listing on the Main Board of the Hong Kong Stock Exchange

Offer Price Between HK$8.60 and HK$9.78 per Share To Raise Proceeds Up to HK$1,947 and 2,214 Million A leading player in China's independent esoteric clinical testing service provider - Kindstar Globalgene Technology, Inc. (Kindstar Globalgene or the Company, together with its subsidiaries, the Group, stock code: 9960.HK), today announced the proposed listing of its shares [...]